Table 6.

Recurrence or delayed onset of severe venom effects

Publication	Patient Identifying Information	Vials of FabAV for Initial Control	Maintenance Therapy Administered?	Recurrent Severe Venom Effects	Delayed Onset Severe Venom Effects
Cohort Studies
Prospective Data Collection
Bush 2002[10]	Patient 14	6	Yes	Limb swelling Limb pain	None
Dart 1997[4]	Patient 10	8	No	Fibrinogen < 50 mg/dl	None
Retrospective Data Collection
Ruha 2002[13]	Patient 1	18	No	Protime > 50 sec	None
				Fibrinogen < 50 mg/dl
Mixed Prospective/Retrospective Data Collection
No cases
Non-Cohort Studies
Camilleri 2005[27]	40-year-old Male	N/A	No	None	Platelet count < 50,000/mm3 INR >5
					Fibrinogen < 50 mg/dl
Fazelat 2008[28]	24-year-old Male	10	Yes	Platelet count < 50,000/mm3	None
Lintner 2006[31]	2-year-old Male	12	No	Platelet count < 50,000/mm3	None
Miller 2002[32]	Case 1	NR	No	None	Fibrinogen < 50 mg/dl
Odeleye 2004[34]	Case 2	N/A	No	INR > 5.0	None
Offerman 2003[35]	42-year-old Male	16	NR	Platelet count < 50,000/mm3	None
Richardson 2007[36]	Case 1	N/A	No	None	Fibrinogen < 50 mg/dl
Seifert 1997[37]	53-year-old Female	6	No	Platelet count < 50,000/mm3	None
Wasserberger 2006[38]	46-year-old Male	N/A	No	Platelet count < 50,000/mm3	None

NR = Not reported

N/A = Not applicable (initial control not obtained)